The global Gene Editing Technology market was valued at US$ 5.3 billion in 2023 and is projected to reach US$ 15.52 billion by 2030, at a CAGR of 15.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
ene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism. Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations
This report contains market size and forecasts of Gene Editing Technology in Global, including the following market information:
- Global Gene Editing Technology Market Size 2025-2030, ($ millions)
We surveyed the Gene Editing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Editing Technology Market, by Type, 2025-2030 ($ millions)
Global Gene Editing Technology Market Segment Percentages, by Type
- Homologous Recombination
- Meganuclease
Global Gene Editing Technology Market, by Application, 2025-2030 ($ millions)
Global Gene Editing Technology Market Segment Percentages, by Application
- Agriculture
- Medical
- Other
Global Gene Editing Technology Market, By Region and Country, 2025-2030 ($ Millions)
Global Gene Editing Technology Market Segment Percentages, by region and country
- United States
- Europe
- Asia
- China
- Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gene Editing Technology revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Gene Editing Technology revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- SIGMA ALDRICH
- Dharmacon
- Cellectics
- CRISPR Therapeutics
- AstraZeneca
- Bio Rad
- Allele Biotech
- Recombinetics
- Lonza
- GE Healthcare
- Editas Medicine
- Agilent Technologies
- QIAGEN NV
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Editing Technology, market overview.
Chapter 2: Global Gene Editing Technology market size in revenue.
Chapter 3: Detailed analysis of Gene Editing Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Editing Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
